[go: up one dir, main page]

SE9903879D0 - Multipor food protection - Google Patents

Multipor food protection

Info

Publication number
SE9903879D0
SE9903879D0 SE9903879A SE9903879A SE9903879D0 SE 9903879 D0 SE9903879 D0 SE 9903879D0 SE 9903879 A SE9903879 A SE 9903879A SE 9903879 A SE9903879 A SE 9903879A SE 9903879 D0 SE9903879 D0 SE 9903879D0
Authority
SE
Sweden
Prior art keywords
drug
tablet
film coating
multipor
essentially
Prior art date
Application number
SE9903879A
Other languages
English (en)
Swedish (sv)
Inventor
Peter Fyhr
Marta Corselli
Staffan Waxegaard
Original Assignee
Ethical Pharmaceuticals Sweden
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethical Pharmaceuticals Sweden filed Critical Ethical Pharmaceuticals Sweden
Priority to SE9903879A priority Critical patent/SE9903879D0/xx
Publication of SE9903879D0 publication Critical patent/SE9903879D0/xx
Priority to DE60032704T priority patent/DE60032704T2/de
Priority to EP00850162A priority patent/EP1095651B1/en
Priority to ES00850162T priority patent/ES2280192T3/es
Priority to JP2000329035A priority patent/JP4711499B2/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE9903879A 1999-10-28 1999-10-28 Multipor food protection SE9903879D0 (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE9903879A SE9903879D0 (sv) 1999-10-28 1999-10-28 Multipor food protection
DE60032704T DE60032704T2 (de) 1999-10-28 2000-10-11 Filmtabletten mit minimierter Abhängigkeit von Nahrungsmitteleinfluss Anfälligkeit
EP00850162A EP1095651B1 (en) 1999-10-28 2000-10-11 Coated tablets having minimised susceptability to food interferance.
ES00850162T ES2280192T3 (es) 1999-10-28 2000-10-11 Comprimidos recubiertos que tienen susceptibilidad minimizada a la interferencia de los alimentos.
JP2000329035A JP4711499B2 (ja) 1999-10-28 2000-10-27 多細孔性食物防護

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9903879A SE9903879D0 (sv) 1999-10-28 1999-10-28 Multipor food protection

Publications (1)

Publication Number Publication Date
SE9903879D0 true SE9903879D0 (sv) 1999-10-28

Family

ID=20417507

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9903879A SE9903879D0 (sv) 1999-10-28 1999-10-28 Multipor food protection

Country Status (5)

Country Link
EP (1) EP1095651B1 (xx)
JP (1) JP4711499B2 (xx)
DE (1) DE60032704T2 (xx)
ES (1) ES2280192T3 (xx)
SE (1) SE9903879D0 (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005104914A (ja) * 2003-09-30 2005-04-21 Kyowa Yakuhin Kogyo Kk 塩基性薬剤含有製剤
NZ556630A (en) * 2005-01-27 2010-12-24 Alembic Ltd Extended release formulation of levetiracetam including a hydrophilic rate controlling polymer
CN101212953A (zh) * 2005-03-29 2008-07-02 麦克内尔-Ppc股份有限公司 具有疏水介质中的亲水药物的组合物
EP2714015B1 (en) * 2011-06-01 2017-03-15 FMC Corporation Controlled release solid dose forms
WO2014158660A1 (en) 2013-03-14 2014-10-02 Dow Global Technologies Llc Composite polyamide membrane including dissolvable polymer coating
WO2022014601A1 (ja) * 2020-07-13 2022-01-20 キリンホールディングス株式会社 フィルムコーティング錠剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4557925A (en) * 1982-07-08 1985-12-10 Ab Ferrosan Membrane-coated sustained-release tablets and method
DE3573884D1 (en) * 1982-07-08 1989-11-30 Leo Ab Substained release tablets and method for preparation thereof
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
FI101344B1 (fi) * 1988-03-31 1998-06-15 Tanabe Seiyaku Co Menetelmä valmistaa valmiste, josta kontrolloidusti vapautuu farmaseuttisesti aktiivista ainetta
IT1256651B (it) * 1992-12-11 1995-12-12 Giancarlo Santus Composizione farmaceutica a rilascio controllato in sospensione liquida
SK279684B6 (sk) * 1993-06-14 1999-02-11 Janssen Pharmaceutica N.V. Tableta a spôsob jej výroby
DK171127B1 (da) * 1994-04-22 1996-06-24 Gea Farmaceutisk Fabrik As Ranitidintablet med et hydroxypropylmethylcelluloseholdigt overtræk samt fremgangsmåde til at tilvejebringe dette overtræk
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
JPH09323926A (ja) * 1996-03-15 1997-12-16 Nikken Chem Co Ltd バルプロ酸ナトリウムの徐放性錠剤
US5916595A (en) * 1997-12-12 1999-06-29 Andrx Pharmaceutials, Inc. HMG co-reductase inhibitor

Also Published As

Publication number Publication date
EP1095651B1 (en) 2007-01-03
JP4711499B2 (ja) 2011-06-29
DE60032704T2 (de) 2007-10-11
JP2001131059A (ja) 2001-05-15
ES2280192T3 (es) 2007-09-16
EP1095651A2 (en) 2001-05-02
DE60032704D1 (de) 2007-02-15
EP1095651A3 (en) 2002-08-21

Similar Documents

Publication Publication Date Title
US6177102B1 (en) Once daily analgesic tablet
AU677833B2 (en) Pharmaceutical tablet capable of releasing the active ingredients contained therein at subsequent times
CA2294744C (en) Multiple unit effervescent dosage form
US7790199B2 (en) Modified release dosage forms of skeletal muscle relaxants
JP3645589B2 (ja) 延長された放出抑制性を有するオピオイド製剤
CA2137017C (en) Controlled release pharmaceutical tablet having lenticular form
KR100823392B1 (ko) 친수성/친유성 중합체 매트릭스 용량적 제제
US8252327B2 (en) Oral controlled release dosage form
CN1119993C (zh) 醋氨酚、假麻黄碱、扑尔敏和可有可无的美沙芬的旋转制粒及包衣
CA2446712C (en) System for osmotic delivery of pharmaceutically active agents
US5830503A (en) Enteric coated diltiazem once-a-day formulation
JPH09502738A (ja) 制御放出のための新規ビーズおよびそれらを含有する医薬製剤
CA2351814A1 (en) Taste masked pharmaceutical particles
EP0822809A4 (en) SLOW RELEASE FORMULATION OF WATER SOLUBLE DRUGS WITH INCORPORATED PASSAGE
CA2470747C (en) Extended release pharmaceutical tablet of metformin
DE69816951D1 (de) Zubereitung enthaltend Cefaclor oder Cephalexin mit modifizierter Freisetzungsmatrix
CN101516351A (zh) 含有卡比多巴和左旋多巴的缓释固态药物组合物
CA2000932A1 (en) Oral pharmaceutical controlled release multiple unit dosage form
IE59409B1 (en) Drug particles having constant release
SE9903879D0 (sv) Multipor food protection
EP1539113A2 (en) Modified release ketoprofen dosage form
AU2007242077B2 (en) Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
El-shattawy et al. Phenylpropanolamine HCL microcapsules: Preparation and release studies
Jethara et al. Aperito Journal of Drug Designing And Pharmacology
Barchielli et al. MULTILAYERED PHARMACEUTICAL FORMULATION